Takano Co. to Co-Host the 91st Pediatric Allergy Association Meeting in Tokyo

Takano Co. to Co-Host the 91st Pediatric Allergy Association Meeting

Takano Co., based in Nagano Prefecture’s Miyata Village under the leadership of Masao Takano, is set to co-host the "91st Pediatric Allergy Association meeting" on September 26, 2026. The event will take place at Sumitomo Real Estate Bellesalle Kanda in Chiyoda, Tokyo, featuring a hybrid format that allows for both in-person and online attendance.

Background of the Event

With a commitment to solving challenges in allergy testing within medical settings, Takano Co. has joined the Pediatric Allergy Association to facilitate a gathering of healthcare professionals involved in pediatric allergy treatment. The meeting aims to share the latest knowledge and foster interactions among medical practitioners. Through presentations and discussions led by renowned experts, participants will examine the current state and future directions of allergy treatment, all with the goal of enhancing the quality of life (QOL) for patients.

Under the theme "Frontiers in Pediatric Allergy Treatment - From Prevention to Innovative Therapies," the meeting will engage in a pro-con format debate addressing crucial questions such as "Is it possible to prevent allergy onset?" and "Is biological treatment the last resort for pediatric atopic dermatitis?" Discussions will be conducted from both pro (support) and con (oppose) perspectives.

Event Details

- Name: 91st Pediatric Allergy Association Meeting
- Theme: Frontiers in Pediatric Allergy Treatment - From Prevention to Innovative Therapies
- Date: September 26, 2026
- Time: 15:00 - 18:00
- Location: Sumitomo Real Estate Bellesalle Kanda 3F Room 1, 7 Kanda Mitoshiromachi, Chiyoda, Tokyo, 101-0053, Japan
- Co-host: Pediatric Allergy Association / Takano Co.
- Format: Hybrid (In-person + Online)

Program Overview

The program will be moderated by designated chairs, with debates leading into each specific theme.

Session 1 (15:10 - 16:20)

- Theme: Is it possible to prevent allergy onset?
- Chair: Dr. Daisuke Hayashi (Tsukuba Medical Center Hospital, Pediatrics)

- Pros: Dr. Kumiko Morita (Tokyo Metropolitan Children’s Medical Center, Pediatrics)
- Cons: Dr. Toshio Katsunuma (Tokyo Jikei University Medical Center, Pediatrics)

Session 2 (16:30 - 17:40)

- Theme: Is biological treatment the last resort for pediatric atopic dermatitis?
- Chair: Dr. Takashi Masuda (Wayo Women's University / Aoyama Allergy Clinic)

- Pros: Dr. Motoki Sekin (Tokyo City Clinic)
- Cons: Dr. Yozo Ishii (Tokyo Jikei University, Dermatology)

Note: The speakers, topics, and start times are subject to change.

Important Notes

This announcement is geared towards medical professionals seeking information about the upcoming meeting.
For media representatives wishing to conduct interviews or photography at the venue, please contact us in advance (deadline: 17:00 the day before the event).

About Takano Co.

Transitioning from a "manufacturing business" to a "creative enterprise," Takano started with spring production and has since expanded into office furniture, exterior products, advanced electronics, and healthcare-related products, continuously embracing new product development. This adaptability defines Takano's identity and drives its progress. Guided by the management philosophy of maintaining high aspirations while adhering to societal rules and anticipating changes, Takano is dedicated to pursuing possibilities from various angles and exploring uncharted territories for sustainable growth and societal contribution.

Company Overview

- Company Name: Takano Co.
- Stock Market: Tokyo Stock Exchange Standard Market (Ticker: 7885)
- Head Office: 137 Miyata Village, Nagano Prefecture
- CEO: Masao Takano
- Founded: July 1, 1941
- Established: July 18, 1953
- Website: https://www.takano-net.co.jp
- Business Scope: Manufacturing and sales of office chairs, various chairs, springs, exterior products, electronics-related products (image processing inspection devices, electromagnetic actuators), and medical and welfare devices.